文献速递慢性肾脏病

慢性肾脏病中心血管疾病患病率随年龄变化:动脉粥样硬化性与非动脉粥样硬化性对比

Prevalence of atheromatous and non-atheromatous cardiovascular disease by age in chronic kidney disease.
PubMed 文献 · Nephrol Dial Transplant · 2020-01-01

基于法国CKD-REIN队列3033例CKD 3-4期患者,分析年龄与eGFR和动脉粥样硬化性及非动脉粥样硬化性心血管疾病的关联。结果显示两类心血管疾病患病率均随年龄增长而升高,85岁以上非动脉粥样硬化性心血管疾病患病率更高。

要点

  • CKD 3-4期患者中动脉粥样硬化性与非动脉粥样硬化性心血管疾病均高度流行。
  • 两类心血管疾病患病率均随年龄增长而显著升高。
  • 85岁以上患者非动脉粥样硬化性心血管疾病患病率高于动脉粥样硬化性。

核心结论

  • 在CKD患者中,动脉粥样硬化性和非动脉粥样硬化性心血管疾病均高度流行,且随年龄增长更常见。
  • 同一年龄组内两类心血管疾病患病率相似,但85岁以上非动脉粥样硬化性心血管疾病患病率更高。

研究设计与样本

  • 基于法国CKD-REIN队列的基线数据,纳入3033例CKD 3-4期患者(65%为男性)。
  • 分析年龄、eGFR与动脉粥样硬化性心血管疾病(冠心病、外周动脉疾病、卒中)和非动脉粥样硬化性心血管疾病(心力衰竭、心律失常、瓣膜性心脏病)的粗率和调整后关联。

主要发现

  • 平均年龄66.8岁,平均CKD-EPI eGFR为32.9 mL/min/1.73 m2。
  • <65、65-74、75-84、≥85岁年龄组动脉粥样硬化性心血管疾病患病率分别为18.7%、35.5%、42.9%、37.8%。
  • <65、65-74、75-84、≥85岁年龄组非动脉粥样硬化性心血管疾病患病率分别为14.9%、28.4%、38.1%、56.4%。
  • 调整白蛋白尿、性别和心血管危险因素后,65-74、75-84、≥85岁组( vs <65岁)动脉粥样硬化性心血管疾病OR分别为1.99(1.61-2.46)、2.89(2.30-3.62)、2.72(1.77-4.18)。
  • 非动脉粥样硬化性心血管疾病相应OR分别为2.07(1.66-2.58)、3.15(2.50-3.97)、7.04(4.67-10.61)。

临床怎么用

  • 在CKD 3-4期患者中应关注随年龄增长的心血管疾病风险,尤其是85岁以上患者的非动脉粥样硬化性心血管疾病。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although chronic kidney disease (CKD) and age are major risk factors for cardiovascular disease (CVD), little is known about the relative proportions of atheromatous and non-atheromatous CVD by age in CKD patients. METHODS: We used baseline data from the French Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) cohort of 3033 patients (65% men) with CKD Stages 3-4 to study crude and adjusted associations between age, the estimated glomerular filtration rate (eGFR), atheromatous CVD (coronary artery disease, peripheral artery disease and stroke) and non-atheromatous CVD (heart failure, cardiac arrhythmia and valvular heart disease). RESULTS: Mean age was 66.8 and mean Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) eGFR was 32.9 mL/min/1.73 m2. In the <65, (65-74), (75-84) and ≥85 year age groups, the prevalence was, respectively, 18.7, 35.5, 42.9 and 37.8% for atheromatous CVD, and 14.9, 28.4, 38.1 and 56.4% for non-atheromatous CVD. After adjusting for albuminuria, sex and CVD risk factors, the odds ratio (OR) [95% confidence interval (CI)] for (65-74), (75-84) and ≥85 age groups (compared with the <65 group) was, respectively, 1.99 (1.61-2.46), 2.89 (2.30-3.62), 2.72 (1.77-4.18) for atheromatous CVD and 2.07 (1.66-2.58), 3.15 (2.50-3.97), 7.04 (4.67-10.61) for non-atheromatous CVD. Compared with patients with an eGFR ≥30 mL/min/1.73 m2, those with an eGFR <30 mL/min/1.73 m2 had a higher OR for atheromatous CVD [1.21 (1.01-1.44)] and non-atheromatous CVD [1.16 (0.97-1.38)]. CONCLUSIONS: In this large cohort of CKD patients, both atheromatous and non-atheromatous CVD were highly prevalent and more frequent in older patients. In a given age group, the prevalence of atheromatous and non-atheromatous CVD was similar (except for a greater prevalence of non-atheromatous CVD after 85).

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Villain C, Metzger M, Combe C, et al. Prevalence of atheromatous and non-atheromatous cardiovascular disease by age in chronic kidney disease. Nephrol Dial Transplant. 2020. PMID: 30169874. doi:10.1093/ndt/gfy277

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。